LabCompass

Naresh Bumma

Medicine · The Ohio State University

Mid career · publishing since 2011

Publications

201

Citations

2,296

Est. group size

~20

Recurring co-author estimate

Active years

16

Publishing since 2011

Research summary
AI-generated

Naresh Bumma's research focuses on multiple myeloma and light chain amyloidosis, two blood cancers involving abnormal plasma cells. Much of the work evaluates new drug combinations and antibody-based treatments (such as daratumumab, linvoseltamab, and other bispecific antibodies) through clinical trials and comparative effectiveness studies, including analyses of treatment safety, quality of life, and outcomes in stem cell transplant candidates.

Multiple myeloma treatmentLight chain amyloidosisBispecific antibody and CAR T-cell therapiesStem cell transplantation in blood cancersComparative drug effectiveness studies

Publication output has grown substantially over the last decade, rising from single digits in 2018-2019 to a sustained pace of over 20 papers per year since 2020, with a peak in 2024.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 23.2/year recently
2017: 12 publications172018: 2 publications182019: 9 publications192020: 29 publications202021: 27 publications212022: 32 publications222023: 17 publications232024: 34 publications34242025: 18 publications252026: 15 publications26
Recent publications
Publishes in
  • Blood×54
  • Clinical Lymphoma Myeloma & Leukemia×25
  • Journal of Clinical Oncology×18
  • Transplantation and Cellular Therapy×11
  • Biology of Blood and Marrow Transplantation×9
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile